Alternatives to blood products

James M. Kelley

doi:10.1007/978-3-319-74588-6_109

Alternatives to blood products

James M. Kelley

Laboratory Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Alternatives to blood products manage anemia and/or thrombocytopenia in patients while avoiding the risks of transfusion. Such strategies help preserve a limited blood supply, reduce exposure to donor blood products and possible transfusion reactions, and control financial costs related to blood. Alternatives can include improving blood production with nutrient supplementation or erythropoietin administration, using surgical techniques such as intraoperative cell salvage or acute normovolemic hemodilution, or administering pharmacologic agents to control bleeding such as antifibrinolytics and purified coagulation factors.

Original language	English (US)
Title of host publication	Oncologic Critical Care
Publisher	Springer International Publishing
Pages	1197-1204
Number of pages	8
ISBN (Electronic)	9783319745886
ISBN (Print)	9783319745879
DOIs	https://doi.org/10.1007/978-3-319-74588-6_109
State	Published - Oct 12 2019

Keywords

Bloodless medicine
Bloodless surgery
Iron supplementation
Patient blood management
Transfusion alternatives

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-74588-6_109

Cite this

@inbook{4cc0c50ab6804129b643b21f5b5ad5d8,

title = "Alternatives to blood products",

abstract = "Alternatives to blood products manage anemia and/or thrombocytopenia in patients while avoiding the risks of transfusion. Such strategies help preserve a limited blood supply, reduce exposure to donor blood products and possible transfusion reactions, and control financial costs related to blood. Alternatives can include improving blood production with nutrient supplementation or erythropoietin administration, using surgical techniques such as intraoperative cell salvage or acute normovolemic hemodilution, or administering pharmacologic agents to control bleeding such as antifibrinolytics and purified coagulation factors.",

keywords = "Bloodless medicine, Bloodless surgery, Iron supplementation, Patient blood management, Transfusion alternatives",

author = "Kelley, {James M.}",

year = "2019",

month = oct,

day = "12",

doi = "10.1007/978-3-319-74588-6_109",

language = "English (US)",

isbn = "9783319745879",

pages = "1197--1204",

booktitle = "Oncologic Critical Care",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Alternatives to blood products

AU - Kelley, James M.

PY - 2019/10/12

Y1 - 2019/10/12

N2 - Alternatives to blood products manage anemia and/or thrombocytopenia in patients while avoiding the risks of transfusion. Such strategies help preserve a limited blood supply, reduce exposure to donor blood products and possible transfusion reactions, and control financial costs related to blood. Alternatives can include improving blood production with nutrient supplementation or erythropoietin administration, using surgical techniques such as intraoperative cell salvage or acute normovolemic hemodilution, or administering pharmacologic agents to control bleeding such as antifibrinolytics and purified coagulation factors.

AB - Alternatives to blood products manage anemia and/or thrombocytopenia in patients while avoiding the risks of transfusion. Such strategies help preserve a limited blood supply, reduce exposure to donor blood products and possible transfusion reactions, and control financial costs related to blood. Alternatives can include improving blood production with nutrient supplementation or erythropoietin administration, using surgical techniques such as intraoperative cell salvage or acute normovolemic hemodilution, or administering pharmacologic agents to control bleeding such as antifibrinolytics and purified coagulation factors.

KW - Bloodless medicine

KW - Bloodless surgery

KW - Iron supplementation

KW - Patient blood management

KW - Transfusion alternatives

UR - http://www.scopus.com/inward/record.url?scp=85086497094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086497094&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-74588-6_109

DO - 10.1007/978-3-319-74588-6_109

M3 - Chapter

AN - SCOPUS:85086497094

SN - 9783319745879

SP - 1197

EP - 1204

BT - Oncologic Critical Care

PB - Springer International Publishing

ER -

Alternatives to blood products

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this